Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Antibody; encephalitis, California (La Crosse)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86651 refers to a laboratory test specifically designed to measure antibodies related to California (La Crosse) encephalitis in either blood or cerebrospinal fluid (CSF). California encephalitis is caused by a mosquito-borne virus belonging to the bunyaviridae family, which typically results in a mild illness, particularly in children during the late summer months. The clinical presentation of this infection often includes symptoms such as a stiff neck and lethargy, which generally appear approximately one week following exposure to the virus and can persist for up to ten days. In some cases, patients may experience seizures either during the acute phase of the infection or as a long-term consequence of the disease. The laboratory test measures specific antibodies: a positive titer for immunoglobulin G (IgG) antibodies indicates either a current or past infection, while a positive titer for immunoglobulin M (IgM) antibodies, when coupled with clinical suspicion of California (La Crosse) viral infection, suggests a current or recent infection. To perform this test, a blood sample is collected through a separately reportable venipuncture, and if CSF is required, it is obtained via a separately reportable lumbar puncture. The testing of both serum and CSF samples is conducted using a semi-quantitative indirect fluorescent antibody technique, which allows for the detection and measurement of these specific antibodies.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 86651 is indicated for the evaluation of potential California (La Crosse) encephalitis infection. The following conditions and symptoms warrant the performance of this laboratory test:

  • Stiff Neck This symptom may indicate meningeal irritation, which can occur in cases of encephalitis.
  • Lethargy A significant decrease in energy or alertness can be a sign of neurological involvement due to infection.
  • Seizures The occurrence of seizures may be associated with acute infection or as sequelae of the disease, necessitating further investigation.
  • Recent Exposure Any recent exposure to mosquitoes in areas where California (La Crosse) encephalitis is endemic may prompt testing for antibodies.

2. Procedure

The procedure for testing antibodies for California (La Crosse) encephalitis involves several key steps, which are outlined below:

  • Step 1: Sample Collection The first step in the procedure is the collection of a blood sample, which is obtained through a venipuncture. This process involves inserting a needle into a vein, typically in the arm, to draw blood. If cerebrospinal fluid (CSF) is also required for testing, a lumbar puncture is performed. This procedure involves inserting a needle into the lower back to collect CSF, which is essential for diagnosing central nervous system infections.
  • Step 2: Laboratory Testing Once the samples are collected, they are sent to the laboratory for analysis. The serum and CSF samples are tested using a semi-quantitative indirect fluorescent antibody technique. This method allows for the detection of specific antibodies (IgG and IgM) against the California (La Crosse) encephalitis virus, providing valuable information regarding the patient's infection status.

3. Post-Procedure

After the procedure, patients may experience some discomfort at the venipuncture or lumbar puncture sites, which is typically mild and resolves quickly. It is important for healthcare providers to monitor patients for any adverse reactions following the lumbar puncture, such as headache or back pain. The results of the antibody testing will be interpreted in conjunction with clinical findings to determine the presence of current or past infection. Follow-up care may include additional diagnostic testing or treatment based on the results and the patient's clinical condition.

Short Descr ENCEPHALITIS CALIFORN ANTBDY
Medium Descr ANTIBODY ENCEPHALITIS CALIFORNIA LA CROSSE
Long Descr Antibody; encephalitis, California (La Crosse)
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 2
CCS Clinical Classification 235 - Other Laboratory
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Date
Action
Notes
2013-01-01 Changed Short Descriptor changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"